Personal profile
Expertises
Medical Oncology
Main research areas
Precision medicine; Early clinical trials; Genomic screening; Personalized oncology
Current research
Personalized medicine in Phase 1 cancer research
Fingerprint
Dive into the research topics where Ida Elisabeth Viller Tuxen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Copenhagen Prospective Personalized Oncology (CoPPO) - Impact of comprehensive genomic profiling in more than 2000 patients in a Phase I setting
Belcaid, L., Højgaard, M., Tuxen, I., Spanggaard, I., Lassen, U., Robinson, L., Rossing, M., Bagger, F., Ahlborn, L. B., Schmidt, A. Y., Hasselby, J. P., Santoni-Rugiu, E., Nielsen, F. C., Yde, C. W. & Rohrberg, K., Sept 2025, In: Annals of Oncology. 36, 9, p. 1078-1087 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
7 Citations (Scopus) -
Mutational Landscape Assessed in Tumor Tissue and Circulating Tumor DNA During Treatment of Patients with HER2/ERBB2-Mutated Solid Tumors
Egebjerg, K., Spanggaard, I., Ahlborn, L. B., Rohrberg, K. S., Harsloef, L., Hoejgaard, M., Schmidt, A. Y., Lassen, U., Tuxen, I. V., Hasselby, J. P., Rossing, M., Santoni-Rugiu, E., Yde, C. W. & Mau-Sørensen, M., 6 Aug 2025, In: BMC Cancer. 25, 1, 1272.Research output: Contribution to journal › Journal article › Research › peer-review
-
Comprehensive analysis of failure to carry out successful genomic profiling in a phase I setting
Belcaid, L., Iden, C., Jacobsen, I., Højgaard, M., Spanggaard, I., Tuxen, I. V., Mau-Sørensen, M., Lassen, U., Yde, C. W. & Rohrberg, K. S., 3 Jun 2024, In: ESMO Open. 9, 6, 103495.Research output: Contribution to journal › Letter › peer-review
3 Citations (Scopus) -
Overall survival after CDK4/6 inhibitor dose reduction in women with metastatic breast cancer
Bjerrum, A., Henriksen, A. F., Knoop, A. S., Berg, T., Tuxen, I. E. V., Lassen, U. & Petersen, T. S., 21 Oct 2024, In: BJC Reports. 2, 1, p. 82Research output: Contribution to journal › Journal article › Research › peer-review
-
New pathogenic germline variants identified in mesothelioma
Belcaid, L., Bertelsen, B., Wadt, K., Tuxen, I., Spanggaard, I., Højgaard, M., Benn Sørensen, J., Ravn, J., Lassen, U., Cilius Nielsen, F., Rohrberg, K. & Westmose Yde, C., 2023, In: Lung Cancer. 179, p. 1-8 8 p., 107172.Research output: Contribution to journal › Review › peer-review
9 Citations (Scopus)